Cibiltech is founded on technical excellence and a deep commitment to patients.
The Paris Transplant Group developed the first universal predictive algorithm for transplantation in 2018 after 20 years of research. Our iBox technology is based on the Paris Transplant Group’s renowned scientific excellence and decades of experience caring for our own transplant patients.
We wanted to help patients worldwide by making our innovative technology available to everyone. With that goal, Alexandre Loupy, Xavier Jouven, and Stephane Tholander founded Cibiltech in 2019.
Together with a team of world-class scientists and business experts, we’re creating a world where science and technology work together in the service of human health.